1. Home
  2. ALT vs CARS Comparison

ALT vs CARS Comparison

Compare ALT & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.17

Market Cap

573.8M

Sector

Health Care

ML Signal

HOLD

Logo Cars.com Inc.

CARS

Cars.com Inc.

HOLD

Current Price

$10.90

Market Cap

546.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALT
CARS
Founded
1997
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Motor Vehicles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
573.8M
546.6M
IPO Year
2005
2017

Fundamental Metrics

Financial Performance
Metric
ALT
CARS
Price
$2.17
$10.90
Analyst Decision
Strong Buy
Hold
Analyst Count
10
6
Target Price
★ $17.11
$13.33
AVG Volume (30 Days)
★ 3.2M
696.9K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 25.37
N/A
EPS
N/A
★ 0.33
Revenue
$41,000.00
★ $723,239,000.00
Revenue This Year
N/A
$0.77
Revenue Next Year
N/A
$2.16
P/E Ratio
★ N/A
$31.27
Revenue Growth
★ 105.00
0.57
52 Week Low
$2.17
$7.40
52 Week High
$6.44
$13.69

Technical Indicators

Market Signals
Indicator
ALT
CARS
Relative Strength Index (RSI) 24.16 56.37
Support Level N/A $10.72
Resistance Level $3.09 $11.68
Average True Range (ATR) 0.11 0.36
MACD -0.03 0.16
Stochastic Oscillator 0.84 96.87

Price Performance

Historical Comparison
ALT
CARS

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About CARS Cars.com Inc.

Cars.com Inc is an audience-powered and data-driven technology platform that simplifies buying and selling cars. The flagship Cars.com marketplace connects consumers to dealerships across the U.S., powering the car-buying experience with artificial intelligence (AI) shopping tools, vehicle reviews and content. Its ecosystem of products enables dealers and OEMs to sell more cars by leveraging the marketplace, dealer websites, trade and appraisal tools and proprietary in-market media solutions. The platform provides shoppers with data, resources and digital tools to make informed buying decisions and connect with automotive retailers. The Company also provides dealerships and OEMs with solutions and data-driven intelligence to reach and influence its 26 million monthly shoppers.

Share on Social Networks: